Cite
HARVARD Citation
Lorente, D. et al. (2018). Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Annals of oncology. pp. 1554-1560. [Online].